Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor Control

April 1, 2024 updated by: National Cheng-Kung University Hospital

Exploration of the Relationships Between Vocational Performances Ans Sensorimotor Factors of Hands in Schizophrenia

The study aims to explore the hand function in people with schizophrenia in the chronic stage.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

37

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Tainan, Taiwan, 701
        • National Cheng-Kung University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Participants with schizophrenia will be recruited from the Department of Internal Medicine in National Cheng Kung University Hospital

Description

Inclusion Criteria:

  • Age between 20-65 years old
  • Diagnosis with schizophrenia or schizoaffective disorder by psychiatrists according to DSM5.
  • Remaining the same antipsychotics and the symptom was stable for at least one month before the study.
  • Be able to follow comments and have sufficient cognitive ability assessed by Mini-Mental State Examination score >24

Exclusion Criteria:

  • Substance abuse or other medical conditions that may affect movements.
  • Using other non-antipsychotics that will affect movements in the same period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
schizophrenia group
No intervention age between 20-65, diagnosed schizophrenia by DSM-5.
Other: no intervention
no intervention in this study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Semmes Weinstein Monofilaments
Time Frame: baseline
Semmes Weinstein Monofilaments is used to assess cutaneous pressure thresholds.
baseline
Pinch-holding-up-activity test
Time Frame: baseline
The pinch apparatus is aims to assess the ability to modulate pinch force to movement-induced load fluctuations in a pinch-holding-up activity (PHUA).
baseline
Manual Tactile Test
Time Frame: baseline
Manual tactile test (MTT) aims to assess the capacity of barognosis, roughness differentiation and stereognosis.
baseline
Purdue pegboard test
Time Frame: baseline
The purpose for Purdue pegboard test is to measure manipulative dexterity including unimanual and bimanual hand dexterity.
baseline
The Valpar 8 simulates assembly work assessment
Time Frame: baseline
Valpar8 simulates the light work and assess the ability of manual dexterity and motor coordination.
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported version of the graphic Personal and Social Performance (SRG-PSP)
Time Frame: baseline
The self-reported version of the graphic personal and social performance is a self-report scale that aims to assess functional performance.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Cheng-Kung University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 17, 2020

Primary Completion (Actual)

July 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

June 20, 2021

First Submitted That Met QC Criteria

June 21, 2021

First Posted (Actual)

June 28, 2021

Study Record Updates

Last Update Posted (Actual)

April 3, 2024

Last Update Submitted That Met QC Criteria

April 1, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • B-ER-109-188

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on no intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe